Latest Close
$28.30
Leadership
ROIV
Roivant Sciences Ltd. Leadership
This leadership view lists the top executives currently surfaced by the company profile source for ROIV.
1y Change
$18.65 (+193.21%)
Market Cap
$20.25B
Sector
Healthcare
Industry
Biotechnology
Recommendation
strong_buy
Mr. Matthew Gline
CEO & Director
Age 41 • Born 1984
$5,715,893.00 total pay
Dr. Eric Venker M.D., Pharm.D.
President & CEO of Immunovant
Age 38 • Born 1987
$6,671,119.00 total pay
Dr. Mayukh Sukhatme M.D.
President, Chief Investment Officer & Director
Age 49 • Born 1976
$81,640,782.00 total pay
Mr. Richard Pulik
Chief Financial Officer
Age 45 • Born 1980
$1,553,179.00 total pay
Ms. Jennifer Humes
Chief Accounting Officer
Age 44 • Born 1981
$324,640.00 total pay
Dr. Frank M. Torti M.B.A., M.D.
President & Vant Chair
Age 46 • Born 1979
Dr. Huafeng Xu Ph.D.
Chief Technology Officer
Age not available
Mr. Ian Rosenblum
Chief Information Officer
Age not available
Mr. Josh Chen J.D.
General Counsel
Age not available
Ms. Kelly Graff
Head of People
Age not available